ORGANIC
LETTERS
2012
Vol. 14, No. 8
2106–2109
Copper-Catalyzed Oxidative
Trifluoromethylation of Terminal Alkenes
Using Nucleophilic CF3SiMe3: Efficient
C(sp3)ꢀCF3 Bond Formation
Lingling Chu† and Feng-Ling Qing*,‡
Key Laboratory of Organofluorine Chemistry, Shanghai Institute of Organic Chemistry,
Chinese Academy of Sciences, 345 Lingling Lu, Shanghai 200032, China, and College of
Chemistry, Chemical Engineering and Biotechnology, Donghua University, 2999 North
Renmin Lu, Shanghai 201620, China
Received March 13, 2012
ABSTRACT
An efficient C(sp3)ꢀCF3 bond-forming reaction via Cu-catalyzed oxidative trifluoromethylation of terminal alkenes has been developed, which
proceeds under mild conditions using readily available, less expensive CF3SiMe3 as the source of the CF3 group. This method allows access to a
variety of trifluoromethylated allylic compounds.
Development of new methods for the incorporation of
the trifluoromethyl group (CF3) into diverse organic mole-
cules is of great importance due to the useful properties
that the trifluoromethyl group imparts on organic mole-
cules such as excellent metabolic stability and high
lipophilicity.1,2 Accordingly, a variety of processes for
the incorporation of the CF3 group into diverse organic
molecules has been developed.2 Transition-metal-
mediated carbonꢀCF3 bond formation reactions have
emerged as powerful synthetic tools in this area.2ꢀ5 For
example, Pd-3 orCu-based4 protocols have been developed
(3) For recent examples, see: (a) Grushin, V. V.; Marshall, W. J.
J. Am. Chem. Soc. 2006, 128, 12644. (b) Ball, N. D.; Kampf, J. W.; Sanford,
M. S. J. Am. Chem. Soc. 2010, 132, 2878. (c) Cho, E. J.; Senecal, T. D.;
Kinzel, T.; Zhang, Y.; Watson, D. A.; Buchwald, S. L. Science 2010, 328,
1679. (d) Cho, E. J.; Buchwald, S. L. Org. Lett. 2011, 13, 6552. (e) Ball,
N. D.; Gary, J. B.; Ye, Y.; Sanford, M. S. J. Am. Chem. Soc. 2011, 133,
7577. (f) Mu, X.; Wu, T.; Wang, H.; Guo, Y.; Liu, G. J. Am. Chem. Soc.
2012, 134, 878. For FeCl2 catalyst: (g) Parsons, A. T.; Senecal., T. D.;
Buchwald, S. L. Angew. Chem., Int. Ed. 2012, 51, 2947.
(4) For recent examples, see: (a) Dubinina, G. G.; Furutachi, H.;
Vicic, D. A. J. Am. Chem. Soc. 2008, 130, 8600. (b) Oishi, M.; Kondo, H.;
Amii, H. Chem. Commun. 2009, 1909. (c) Chu, L.; Qing, F.-L. Org. Lett.
2010, 12, 5060. (d) Senecal, T. D.; Parsons, A. T.; Buchwald, S. L. J. Org.
Chem. 2011, 76, 1174. (e) Kondo, H.; Oishi, M.; Fujikawa, K.; Amii, H.
Adv. Synth. Catal. 2011, 353, 1247. (f) Zhang, C.-P.; Wang, Z.-L.; Chen,
Q.-Y.; Zhang, C.-T.; Gu, Y.-C.; Xiao, J.-C. Angew. Chem., Int. Ed. 2011,
50, 1896. (g) Morimoto, H.; Tsubogo, T.; Litvinas, N. D.; Hartwig, J. F.
Angew. Chem., Int. Ed. 2011, 50, 3793. (h) Knauber, T.; Arikan, F.;
Roschenthaler, G.-V.; Gooβen, L. J. Chem.;Eur. J. 2011, 17, 2689. (i)
Liu, T.; Shen, Q. Org. Lett. 2011, 13, 2342. (j) Xu, J.; Luo, D.-F.; Xiao,
B.; Liu, Z.-J.; Gong, T.-J.; Fu, Y.; Liu, L. Chem. Commun. 2011, 47,
4300. (k) Zhang, C.-P.; Cai, J.; Zhou, C. -B.; Wang, X.-P.; Zheng, X.;
Gu, Y.-C.; Xiao, J.-C. Chem. Commun. 2011, 47, 9516. (l) Tomashenko,
O. A.; Escudero-Adan, E. C.; Belmonte, M. M.; Grushin, V. V. Angew.
Chem., Int. Ed. 2011, 50, 7655. (m) Hafner, A.; Brase, S. Adv. Synth.
Catal. 2011, 353, 3044. (n) Weng, Z.; Lee, R.; Jia, W.; Yuan, Y.; Wang,
W.; Feng, X.; Huang, K.-W. Organometallics 2011, 30, 3229. (o) Popov,
I.; Lindeman, S.; Daugulis, O. J. Am. Chem. Soc. 2011, 133, 9286. (p)
Zanardi, A.; Novikov, M. A.; Martin, E.; Benet-Buchholz, J.; Grushin,
V. V. J. Am. Chem. Soc. 2011, 133, 20901.
† Shanghai Institute of Organic Chemistry.
‡ Donghua University.
(1) For selected reviews, see: (a) Kirsch, P. Modern Fluoroorganic
Chemistry; Wiley-VCH: Weinheim, 2004. (b) Uneyama, K. Organofluorine
Chemistry; Blackwell: Oxford, U.K., 2006. (c) Ojima, I. Fluorine in
Medicinal Chemistry and Chemical Biology; Wiley-Blackwell: Chichester,
U.K., 2009. (d) Muller, K.; Faeh, C.; Diederich, F. Science 2007, 317, 1881.
(e) Hird, M. Chem. Soc. Rev. 2007, 36, 2070. (f) Kirk, K. L. Org. Process
Res. Dev. 2008, 12, 305. (g) O’Hagan, D. Chem. Soc. Rev. 2008, 37, 308.
(h) Filler, R; Saha, R. Future Med. Chem. 2009, 1, 777. (i) Daniels, S.;
Tohid, S. F. M.; Velanguparackel, W.; Westwell, A. D. Expert Opin.
Drug Discovery 2010, 5, 291. (j) Acena, J. L.; Simon-Fuentes, A.;
Fustero, S. Curr. Org. Chem. 2010, 14, 928.
(2) For recent reviews, see: (a) Schlosser, M. Angew. Chem., Int. Ed.
2006, 45, 5432. (b) Lundgren, R. J.; Stradiotto, M. Angew. Chem., Int.
Ed. 2010, 49, 9322. (c) Roy, S.; Gregg, B. T.; Gribble, G. W.; Le, V.-D.;
Roy, S. Tetrahedron 2011, 67, 2161. (d) Tomashenko, O. A.; Grushin,
V. V. Chem. Rev. 2011, 111, 4475. (e) Furuya, T.; Kamlet, A. S.; Ritter,
T. Nature 2011, 473, 470.
r
10.1021/ol300639a
Published on Web 04/12/2012
2012 American Chemical Society